Skip to content
10-K

Annual Report

ALNYLAM PHARMACEUTICALS, INC. ALNY

0001628280-26-007497

← back to feed
Filed
Feb 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 6, 2026 132.62M sh
Shares Diluted FY 2025 · Dec 31, 2025 134.68M sh
Shares Diluted FY 2025 · Dec 31, 2024 127.65M sh
Shares Diluted FY 2025 · Dec 31, 2023 124.91M sh
Capex FY 2025 · Dec 31, 2025 $58.7M
Capex FY 2025 · Dec 31, 2024 $34.28M
Capex FY 2025 · Dec 31, 2023 $62.21M
Operating Cash Flow FY 2025 · Dec 31, 2025 $524.08M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$8.31M
Operating Cash Flow FY 2025 · Dec 31, 2023 $104.16M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.66B
Cash And Equivalents FY 2025 · Dec 31, 2024 $966.43M
Cash And Equivalents FY 2025 · Dec 31, 2023 $812.69M
Stockholders Equity FY 2025 · Dec 31, 2025 $789.18M
Stockholders Equity FY 2025 · Dec 31, 2024 $67.09M
Stockholders Equity FY 2025 · Dec 31, 2023 −$220.64M
Stockholders Equity FY 2025 · Dec 31, 2022 −$158.22M
Current Liabilities FY 2025 · Dec 31, 2025 $1.47B
Current Liabilities FY 2025 · Dec 31, 2024 $1.19B
Total Liabilities FY 2025 · Dec 31, 2025 $4.18B
Total Liabilities FY 2025 · Dec 31, 2024 $4.17B
Current Assets FY 2025 · Dec 31, 2025 $4.05B
Current Assets FY 2025 · Dec 31, 2024 $3.3B
Total Assets FY 2025 · Dec 31, 2025 $4.97B
Total Assets FY 2025 · Dec 31, 2024 $4.24B
Eps Diluted FY 2025 · Dec 31, 2025 $2.33
Eps Diluted FY 2025 · Sep 30, 2025 $1.51
Eps Diluted FY 2025 · Jun 30, 2025 −$0.70
Eps Diluted FY 2025 · Mar 31, 2025 −$0.14
Eps Diluted FY 2025 · Dec 31, 2024 −$2.18
Eps Diluted FY 2025 · Dec 31, 2023 −$3.52
Eps Basic FY 2025 · Dec 31, 2025 $2.39
Eps Basic FY 2025 · Sep 30, 2025 $1.55
Eps Basic FY 2025 · Jun 30, 2025 −$0.70
Eps Basic FY 2025 · Mar 31, 2025 −$0.14
Eps Basic FY 2025 · Dec 31, 2024 −$2.18
Eps Basic FY 2025 · Dec 31, 2023 −$3.52
Sga Expense FY 2025 · Dec 31, 2025 $1.21B
Sga Expense FY 2025 · Dec 31, 2024 $975.53M
Sga Expense FY 2025 · Dec 31, 2023 $795.65M
Rd Expense FY 2025 · Dec 31, 2025 $1.32B
Rd Expense FY 2025 · Dec 31, 2024 $1.13B
Rd Expense FY 2025 · Dec 31, 2023 $1B
Net Income FY 2025 · Dec 31, 2025 $313.75M
Net Income FY 2025 · Sep 30, 2025 $202.2M
Net Income FY 2025 · Jun 30, 2025 −$90.48M
Net Income FY 2025 · Mar 31, 2025 −$18.25M
Net Income FY 2025 · Dec 31, 2024 −$278.16M
Net Income FY 2025 · Dec 31, 2023 −$440.24M
Operating Income FY 2025 · Dec 31, 2025 $501.58M
Operating Income FY 2025 · Dec 31, 2024 −$176.89M
Operating Income FY 2025 · Dec 31, 2023 −$282.18M
Cost Of Revenue FY 2025 · Dec 31, 2025 $677.17M
Cost Of Revenue FY 2025 · Dec 31, 2024 $306.51M
Cost Of Revenue FY 2025 · Dec 31, 2023 $268.22M
Revenue FY 2025 · Dec 31, 2025 $3.71B
Revenue FY 2025 · Dec 31, 2024 $2.25B
Revenue FY 2025 · Dec 31, 2023 $1.83B